corporate_fare
Oblenio Bio Inc.
- Address
- 1111 Broadway Suite 1300
Sponsor Overview
assignment
1
sponsored trial
science
0
molecules
location_city
2
research centres
public
1
country
person_search
2
investigators
Sponsored Trials
| Trial Name | Country | Status |
|---|---|---|
| Phase 1, Open‑Label Study of LBL‑051 in Adults with Refractory B‑cell–Mediated Autoimmune Diseases |  Germany | Recruiting |
Data & Insights
science
Molecule Portfolio
Compounds under investigation
0
Exclusive Molecules
out of 0 total (0% not shared with other sponsors)
This sponsor works with 0 molecules, of which 0 are not being studied by other sponsors.
hub
Site Partnerships
Collaboration with research centres
0%
Return partnership rate
0 of 2 sites collaborated multiple times
This sponsor has worked with 2 sites across their trial portfolio.
Therapeutic Focus
- 1.Immune system processes1 trial65 other sponsors
Partnered Research Centres
2 centreslocation_city
assignment52Johannes Wesling Klinikum Minden
- Address
- Hans-Nolte-Strasse 1, Haeverstaedt, 32429 Minden
location_city
assignment394Universitaetsklinikum Erlangen AöR
- Address
- Ulmenweg 18, Innenstadt, 91054 Erlangen
Want to get in touch with this sponsor?
Send a question and we'll pass it on to Oblenio Bio Inc..
Need a custom report on this sponsor?
Competitive positioning, market entry, partnership opportunities — tell us the question.
Is something out of date?
Tell us what needs correcting and we'll update this profile.